Amanullah Siddiqi, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1285 Highway 11w, Bean Station, TN 37708 Phone: 865-993-4300 Fax: 865-993-4304 |
News Archive
Patients experiencing symptoms such as chest pain who received from paramedics an intravenous solution consisting of glucose-insulin-potassium (GIK) had no reduction in the rate of progression to heart attack and no improvement in 30-day survival, although GIK was associated with a lower rate of the composite outcome of cardiac arrest or in-hospital death, according to a study appearing in JAMA.
Mitch DeKoven, Director, HEOR, Real-World Evidence Solutions, IMS Health Inc. and Won Chan Lee, Ph.D., Principal, Health Economics and Outcomes Research, IMS Health, Inc. will present Optimizing Strategic Direction with Systematic Value Development at the Pharmaceutical Market Access Pricing and Reimbursement Conference in San Francisco on October 29, 2013.
Health care practitioners now can access patients' data using electronic medical records, which often include information systems that assess individuals' medical histories and clinical research to facilitate doctors' diagnoses.
BerGenBio has secured NOK7 million from local Sarsia Seed and Development funds to continue its leading research and development activities into new and original cancer treatments.
Pharmaceutical scientists typically face a meager five percent success rate for anti-cancer drugs in clinical trials. To help improve this success rate, Japanese scientists, led by Dr. Tetsuya Terasaki, one of the top pharmaceutical scientists focused on drug transporters, have developed a new approach designed to overcome complexities of developing new, more effective drugs to treat diseases, including cancer.
› Verified 2 days ago